ScreenerHero

BIOVBioVaxys Technology Corp.

CNQ · CA · Healthcare · Biotechnology · biovaxys.com
0.0700CAD0.00%Mkt Cap: 2.07M $P/E: —

BioVaxys Technology Corp., a clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics. The company offers DPX immune educating technology platform and HapTen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.07M $
Enterprise Value1.58M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.88M $
Revenue/Share—
Last Price0.0700 CAD
Fiscal Year EndOct 2024
MR QuarterJul 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA09076M1014
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.56
EPS (TTM)-0.24
EPS (Forward)—
52W Range
0.030011% of range0.4000
52W High0.4000 CAD
52W Low0.0300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE205.97%
ROA-304.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.36M $
CapEx (TTM)769.31K $
FCF Margin—
FCF Yield-36.14%
Net Debt94.41K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.04
Current Ratio0.28
Quick Ratio0.10
Book Value/Sh-0.1250 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 11, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.40.65M
Float26.14M
Insiders8.23%
Institutions0.00%
Short Interest
Short % Out.0.00%
Shares Short1.56K
Short (prev mo.)1.56K
Technical
SMA 500.0700 (+0.0%)
SMA 2000.1265 (-44.7%)
Beta1.09
S&P 52W Chg18.16%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)54.0
MACD0.0001
MACD Signal0.0001
MACD Hist.-0.0000
BB Upper0.0700 CAD
BB Middle0.0700 CAD
BB Lower0.0700 CAD
BB Width0.00%
ATR (14)0.0001 CAD
Vol Ratio (20d)—